Search

REAL WORLD OUTCOMES IN PATIENTS WITH HNSCC TREATED WITH CHECKPOINT INHIBITION

Immunotherapy / Systemic Therapy

Sara B Hobday¹; Robert M Brody, MD¹; Barry A Kriegsman, MD, PhD¹; Devraj Basu, MD, PhD, FACS²; Jason Newman, MD, FACS¹; Roger B Cohen, MD³; Abigail Doucette⁴; Lova Sun, MD, MSCE⁵

¹Department of Otorhinolaryngology: Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; ²Department of Otorhinolaryngology: Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, The Wistar Institute, Philadelphia, PA; ³Abramson Cancer Center of the University of Pennsylvania, Philadelphia PA; ⁴Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia PA; ⁵Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA